BioCentury
ARTICLE | Clinical News

Aerospan flunisolide regulatory update

February 6, 2006 8:00 AM UTC

FDA approved an NDA for Aerospan flunisolide as maintenance treatment of asthma as prophylactic therapy in patients 6 years of age and older. Aerospan is a hydrofluoroalkane (HFA) formulated inhaled c...